ProfileGDS4459 / ENSG00000133313
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 84% 86% 94% 88% 90% 84% 95% 94% 91% 95% 83% 94% 94% 76% 94% 79% 87% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 16.4184
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 26.5686
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 38.0194
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 46.788
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 57.2890
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 66.4584
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 78.2395
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 87.9394
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 97.5891
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 108.0695
GSM623474group B, liver allograft wedge biopsie placebo treatment 16.4483
GSM623475group B, liver allograft wedge biopsie placebo treatment 28.0394
GSM623476group B, liver allograft wedge biopsie placebo treatment 37.994
GSM623477group B, liver allograft wedge biopsie placebo treatment 45.5476
GSM623478group B, liver allograft wedge biopsie placebo treatment 58.0294
GSM623479group B, liver allograft wedge biopsie placebo treatment 65.7979
GSM623480group B, liver allograft wedge biopsie placebo treatment 76.7987